What is the ICD-10 code for chronic myeloid leukemia?

The ICD-10 code for chronic myeloid leukemia varies by phase: C92.10 for remission, C92.11 for relapse, and C92.12 for accelerated phase.

How do you code chronic myeloid leukemia in remission?

Use ICD-10 code C92.10 for chronic myeloid leukemia in remission, ensuring documentation of molecular response.

ICD-10 Coding for Chronic Myeloid Leukemia(C92.10, C92.1, C92.11)

Save

Explore comprehensive ICD-10 coding guidelines for chronic myeloid leukemia, including phase-specific codes and documentation requirements.

Also known as:

CMLChronic Myelogenous LeukemiaChronic Granulocytic Leukemia

Related ICD-10 Code Ranges

Complete code families applicable to Chronic Myeloid Leukemia

C00-D49Primary Range

Neoplasms

→

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

Code	Description	When to Use	Key Documentation
C92.10	Chronic myeloid leukemia, BCR/ABL-positive, in remission	Use when the patient is in remission with documented molecular response.	Major molecular response sustained for ≥12 months Last 2 qPCR results showing ≤0.01% IS
C92.11	Chronic myeloid leukemia, BCR/ABL-positive, in relapse	Use when the patient shows evidence of relapse with rising BCR/ABL1 levels.	Two consecutive BCR/ABL1 IS results >0.1% Peripheral blood blasts >15%
C92.12	Chronic myeloid leukemia, BCR/ABL-positive, in accelerated phase	Use when the patient is in the accelerated phase with documented clinical features.	10-19% blasts in PB/BM Basophils ≥20% Platelets <100k unrelated to therapy

Primary ICD-10-CM Codes

Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission

C92.10Billable

Differential Codes

Alternative codes to consider when ruling out similar conditions

Chronic myeloid leukemia, BCR/ABL-positive, in relapseC92.11

Chronic myeloid leukemia, BCR/ABL-positive, in remissionC92.10

Documentation & Coding Risks

Avoid these common issues when documenting Chronic Myeloid Leukemia.

Using unspecified CML code

Impact

Clinical: Leads to inappropriate treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement.

Mitigation

Always specify the phase of CML., Document molecular response.

Coding CML without specifying the phase

Impact

Reimbursement: Incorrect phase coding can lead to reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Impacts the accuracy of clinical data.

Mitigation

Always document and code the specific phase of CML.

Phase documentation

Impact

Failure to document the phase of CML can lead to audit issues.

Mitigation

Implement phase-specific documentation templates.

Frequently Asked Questions

Documentation requirements, coding pitfalls and FAQs for conditions coded with C92.10.

Primary Code

C92.10

Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission

Quick Navigation

ICD-10 codes4

Coding risks3

FAQs2

ICD-10 Coding for Chronic Myeloid Leukemia(C92.10, C92.1, C92.11)

Documentation & Coding Risks

Frequently Asked Questions

What is the ICD-10 code for chronic myeloid leukemia?

How do you code chronic myeloid leukemia in remission?

Related condition guides